New US Rule a Blow to Indian Pharma Exporters

  • The U.S. government has made it mandatory for Active Pharmaceutical Ingredients (APIs) to be manufactured locally.
  • At present, nearly 80 per cent of drug raw material requirement is met by India or China.
  • The decision has sent Indian pharmaceutical exporters into a tizzy, as it will significantly impact Indian drug exports.
  • India’s pharmaceutical Export Promotion Council has approached the Commerce Ministry, requesting authorities to intervene and resolve the issue.